Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can eating soon after stoma reversal surgery prevent dangerous leaks?

NCT ID NCT07730333

Disease control Sponsor: Allied Hospital Faisalabad Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 28, 2026 · Last updated Jul 29, 2026 · Updated 1 time

Summary

This trial tests whether starting oral feeding within 24 hours after ileostomy reversal surgery is safer than waiting 48 to 72 hours for bowel function to return. The main question is whether early feeding reduces the chance of anastomotic leakage, a serious complication where intestinal contents leak through the surgical connection. The study includes 420 adults aged 18 to 70 undergoing elective ileostomy reversal, excluding those with active infection, advanced cancer, or extensive bowel resection.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
early oral feeding protocol (liquids or solid food within 24 hours after surgery) compared to delayed oral feeding (nothing by mouth until bowel function returns, typically 48-72 hours)
What this could lead to
If early feeding is safe, it could shorten hospital stays and speed recovery for patients undergoing ileostomy reversal.
What could go wrong
This is a single-center trial, and results may not apply to all patients. Early feeding might increase the risk of complications like leakage in some individuals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

420 people

The number who actually took part.

Started

Mar 2026

Finished

Jul 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients undergoing elective ileostomy reversal surgery * age between 18 and 70 years * patient provided informed consent Exclusion Criteria: * patients with active active peritonitis * Advanced malignancy * Patients requiring extensive bowel resection

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Malignancies multiple are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Malignancies multiple

Contacts and locations

Locations

  • Allied hospital Faisalabad

    Faisalābad, Punjab Province, 38000, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.